Total Payments
$30,434
2024 Payments
$17,482
Companies
27
Transactions
268
Medicare Patients
2,044
Medicare Billing
$282,949
Payment Breakdown by Category
Travel$13,733 (45.1%)
Food & Beverage$10,093 (33.2%)
Consulting$6,290 (20.7%)
Other$162.03 (0.5%)
Education$156.43 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $13,733 | 36 | 45.1% |
| Food and Beverage | $10,093 | 225 | 33.2% |
| Consulting Fee | $6,290 | 4 | 20.7% |
| Grant | $162.03 | 1 | 0.5% |
| Education | $156.43 | 2 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Vertos Medical, Inc. | $12,756 | 18 | $0 (2024) |
| Abbott Laboratories | $6,890 | 61 | $0 (2024) |
| Medtronic, Inc. | $2,578 | 42 | $0 (2024) |
| Saluda Medical Americas, Inc. | $1,997 | 18 | $0 (2024) |
| Nevro Corp. | $1,566 | 26 | $0 (2024) |
| Boston Scientific Corporation | $1,021 | 14 | $0 (2024) |
| Curonix LLC | $689.22 | 10 | $0 (2024) |
| Bioventus LLC | $550.79 | 4 | $0 (2023) |
| BIOTRONIK NRO, Inc. | $509.13 | 9 | $0 (2024) |
| SPR Therapeutics, Inc | $415.33 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17,482 | 118 | Vertos Medical, Inc. ($12,453) |
| 2023 | $10,413 | 97 | Abbott Laboratories ($5,907) |
| 2022 | $1,558 | 29 | Medtronic, Inc. ($817.60) |
| 2021 | $760.77 | 9 | SPR Therapeutics, Inc ($224.28) |
| 2019 | $79.61 | 5 | Janssen Pharmaceuticals, Inc ($79.61) |
| 2018 | $42.43 | 3 | PFIZER INC. ($28.06) |
| 2017 | $98.80 | 7 | E.R. Squibb & Sons, L.L.C. ($31.77) |
All Payment Transactions
268 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Medtronic, Inc. | ACCURIAN (Device) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 12/19/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $110.64 | General |
| Category: Not Applicable | ||||||
| 12/13/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $5.72 | General |
| Category: Not Applicable | ||||||
| 12/09/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $14.33 | General |
| Category: Opioid Analgesic | ||||||
| 12/09/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $11.42 | General |
| Category: Opioid Analgesic | ||||||
| 12/06/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $8.09 | General |
| Category: Spinal Cord Stimulator | ||||||
| 12/05/2024 | Atland Pharmaceuticals, LLC | ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE (Drug), TOLMETIN SODIUM | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: Pain | ||||||
| 11/06/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $72.51 | General |
| 10/31/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $20.00 | General |
| Category: Opioid Analgesic | ||||||
| 10/14/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $164.31 | General |
| Category: Neuromodulation | ||||||
| 10/02/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $8.16 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/01/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $23.44 | General |
| 09/26/2024 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Food and Beverage | In-kind items and services | $10.81 | General |
| Category: PAIN MANAGEMENT | ||||||
| 09/19/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Spinal Cord Stimulator | ||||||
| 09/18/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $14.58 | General |
| Category: Opioid Analgesic | ||||||
| 09/17/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: Spinal Cord Stimulator | ||||||
| 09/16/2024 | PAINTEQ LLC | PAINTEQ (Device) | Food and Beverage | In-kind items and services | $31.58 | General |
| Category: PAIN MANAGEMENT | ||||||
| 09/13/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: Neuromodulation | ||||||
| 09/13/2024 | Nalu Medical, Inc. | Nalu Neurostimulation System (Device) | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: Pain Management | ||||||
| 09/13/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $16.31 | General |
| Category: Opioid Analgesic | ||||||
| 09/12/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $1.32 | General |
| Category: Opioid Analgesic | ||||||
| 09/11/2024 | Vertos Medical, Inc. | mild Device Kit (Device) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: Orthopedic | ||||||
| 08/30/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $5.13 | General |
| Category: Opioid Analgesic | ||||||
| 08/27/2024 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Food and Beverage | In-kind items and services | $90.81 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/21/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Spinal Cord Neurostimulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,550 | 2,702 | $1.4M | $229,415 |
| 2022 | 10 | 494 | 614 | $293,893 | $53,534 |
Total Patients
2,044
Total Services
3,316
Medicare Billing
$282,949
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 260 | 505 | $163,794 | $46,770 | 28.6% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 275 | 650 | $208,624 | $38,848 | 18.6% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 132 | 246 | $295,296 | $37,751 | 12.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 261 | 557 | $121,983 | $34,807 | 28.5% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 99 | 174 | $174,068 | $19,512 | 11.2% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 60 | 62 | $86,824 | $11,954 | 13.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 56 | 56 | $27,888 | $6,327 | 22.7% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 30 | 30 | $55,650 | $5,749 | 10.3% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2023 | 46 | 46 | $16,100 | $4,339 | 27.0% |
| 96130 | Evaluation of psychological test, first hour | Office | 2023 | 46 | 46 | $16,100 | $4,035 | 25.1% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 26 | 36 | $35,246 | $3,146 | 8.9% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2023 | 27 | 30 | $26,524 | $2,178 | 8.2% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 11 | 14 | $24,000 | $2,079 | 8.7% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 30 | 30 | $26,553 | $1,852 | 7.0% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 25 | 35 | $17,428 | $1,786 | 10.2% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 16 | 17 | $13,353 | $1,714 | 12.8% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 15 | 18 | $12,510 | $1,351 | 10.8% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Facility | 2023 | 11 | 15 | $11,810 | $1,229 | 10.4% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2023 | 46 | 46 | $4,600 | $1,150 | 25.0% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 11 | 18 | $11,000 | $967.16 | 8.8% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Facility | 2023 | 12 | 16 | $5,828 | $716.27 | 12.3% |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | Office | 2023 | 22 | 22 | $2,200 | $588.16 | 26.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 33 | 33 | $3,300 | $564.92 | 17.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 134 | 180 | $39,420 | $12,580 | 31.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 86 | 104 | $33,696 | $10,456 | 31.0% |
About Dr. Sushanth Boda, DO
Dr. Sushanth Boda, DO is a Interventional Pain Medicine healthcare provider based in Newnan, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/19/2017. The National Provider Identifier (NPI) number assigned to this provider is 1780114975.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sushanth Boda, DO has received a total of $30,434 in payments from pharmaceutical and medical device companies, with $17,482 received in 2024. These payments were reported across 268 transactions from 27 companies. The most common payment nature is "Travel and Lodging" ($13,733).
As a Medicare-enrolled provider, Boda has provided services to 2,044 Medicare beneficiaries, totaling 3,316 services with total Medicare billing of $282,949. Data is available for 2 years (2022–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Pain Medicine
- Other Specialties Pain Medicine, Anesthesiology
- Location Newnan, GA
- Active Since 06/19/2017
- Last Updated 10/31/2025
- Taxonomy Code 208VP0014X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1780114975
Products in Payments
- mild Device Kit (Device) $12,756
- PROCLAIM (Device) $6,847
- Evoke (Device) $1,997
- Senza (Device) $1,399
- INTELLIS ADAPTIVESTIM (Device) $1,277
- VANTA ADAPTIVESTIM (Device) $1,015
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) $679.41
- Stimrouter Implantable Kit (Device) $550.79
- Prospera (Device) $489.68
- SPRINT PNS System (Device) $415.33
- Intracept (Device) $342.65
- WAVEWRITER ALPHA (Device) $201.21
- Belbuca (Drug) $195.93
- Omnia (Device) $167.06
- General - Pain Management (Device) $142.09
- Nalu Neurostimulation System (Device) $136.13
- RESTORE (Device) $129.27
- Superion Indirect Decompression System (Device) $83.33
- XTAMPZA (Drug) $82.37
- XARELTO (Drug) $79.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.